GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 48 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,971,000 | +7.8% | 10,376,936 | 0.0% | 0.38% | +54.3% |
| Q4 2021 | $12,037,000 | -39.6% | 10,376,936 | 0.0% | 0.24% | +2.5% |
| Q3 2021 | $19,924,000 | -17.9% | 10,376,936 | 0.0% | 0.24% | -25.0% |
| Q2 2021 | $24,282,000 | -13.7% | 10,376,936 | 0.0% | 0.32% | -49.9% |
| Q1 2021 | $28,121,000 | +12.0% | 10,376,936 | 0.0% | 0.63% | -4.8% |
| Q4 2020 | $25,112,000 | +5.7% | 10,376,936 | 0.0% | 0.66% | -34.1% |
| Q3 2020 | $23,763,000 | +43.0% | 10,376,936 | +43.6% | 1.01% | +50.6% |
| Q2 2020 | $16,619,000 | +33.7% | 7,225,676 | 0.0% | 0.67% | +2.9% |
| Q1 2020 | $12,428,000 | – | 7,225,676 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $435,000 | 25.16% |
| COMMODORE CAPITAL LP | 3,079,756 | $3,573,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $2,288,000 | 0.26% |
| NEA Management Company, LLC | 10,376,936 | $12,037,000 | 0.24% |
| BVF INC/IL | 4,012,404 | $4,654,000 | 0.17% |
| Avoro Capital Advisors LLC | 5,084,184 | $5,898,000 | 0.10% |
| Boxer Capital, LLC | 1,134,453 | $1,316,000 | 0.05% |
| Ikarian Capital, LLC | 196,821 | $228,000 | 0.03% |
| Empirical Asset Management, LLC | 10,000 | $12,000 | 0.01% |
| Point72 Asset Management, L.P. | 2,652,974 | $3,077,000 | 0.01% |